Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population

Gene

Volumn 512, Issue 2, 2013, Pages 300-304

  Guo, Ting ^a   Huo, Ya'nan ^b   Zhu, Wei ^a   Xu, Fanghua ^b   Liu, Changqin ^a   Liu, Nan ^a   Cao, Min ^a   Cui, Bin ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JIANGXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Autoimmune disease; Graves' Disease; Interleukin 17F; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 17F;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84870364058     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.021     Document Type: Article

References (40)

1. Antonelli A., et al. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur. J. Endocrinol. 2006, 154:651-658.
2. Arisawa T., et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J. Clin. Immunol. 2008, 28:44-49.
3. Ban Y., Tozaki T., Taniyama M., Nakano Y., Hirano T. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid 2010, 20:893-899.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Bruck P., et al. A CXC motif ligand 10 polymorphism as a marker to predict severity of Graves' disease. Thyroid 2010, 20:343-345.
6. Chistiakov D.A. Thyroid-stimulating hormone receptor and its role in Graves' disease. Mol. Genet. Metab. 2003, 80:377-388.
7. Chistiakov D.A., Savost'anov K.V., Turakulov R.I. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab. 2004, 83:264-270.
8. Chistyakov D.A., et al. Complex association analysis of Graves disease using a set of polymorphic markers. Mol. Genet. Metab. 2000, 70:214-218.
9. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 1998, 19:589-601.
10. Figueroa-Vega N., Alfonso-Perez M., Benedicto I., Sanchez-Madrid F., Gonzalez-Amaro R., Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 2010, 95:953-962.
11. Gianoukakis A.G., Khadavi N., Smith T.J. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 2008, 18:953-958.
12. Gu L.Q., et al. Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy. Endocrine 2009, 36:452-456.
13. Hayashi F., Watanabe M., Nanba T., Inoue N., Akamizu T., Iwatani Y. Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells. Clin. Exp. Immunol. 2009, 158:281-286.
14. Huber A.K., Jacobson E.M., Jazdzewski K., Concepcion E.S., Tomer Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 2008, 93:1077-1081.
15. Hurst S.D., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 2002, 169:443-453.
16. Ishigame H., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119.
17. Jang W.C., et al. Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease. Rheumatol. Int. 2008, 29:173-178.
18. Kawaguchi M., et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 2001, 167:4430-4435.
19. Kawaguchi M., Adachi M., Oda N., Kokubu F., Huang S.K. IL-17 cytokine family. J. Allergy Clin. Immunol. 2004, 114:1265-1273.
20. Kawaguchi M., et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol. 2006, 117:795-801.
21. Liao W.L., et al. Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males. BMC Med. Genet. 2010, 11:154.
22. McAllister F., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 2005, 175:404-412.
23. Meller J., Jauho A., Hufner M., Gratz S., Becker W. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 2000, 10:1073-1079.
24. Metzger K., Fremont M., Roelant C.De, Meirleir K. Lower frequency of IL-17F sequence variant (His161Arg) in chronic fatigue syndrome patients. Biochem. Biophys. Res. Commun. 2008, 376:231-233.
25. Mitchell A.L., et al. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 2009, 94:5139-5145.
26. Nanba T., Watanabe M., Inoue N., Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009, 19:495-501.
27. Oda N., Canelos P.B., Essayan D.M., Plunkett B.A., Myers A.C., Huang S.K. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am. J. Respir. Crit. Care Med. 2005, 171:12-18.
28. Oishi Y., et al. The IL6 gene polymorphism -634C>G and IL17F gene polymorphism 7488T>C influence bone mineral density in young and elderly Japanese women. Gene 2012, 504:75-83.
29. Paradowska-Gorycka A., Wojtecka-Lukasik E., Trefler J., Wojciechowska B., Lacki J.K., Maslinski S. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand. J. Immunol. 2010, 72:134-141.
30. Puel A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
31. Saitoh T., et al. Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia. Eur. J. Haematol. 2011, 87:253-258.
32. Shi Y., et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand. J. Immunol. 2010, 72:250-255.
33. Shu Q., et al. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behcet's disease in a Chinese Han population. Hum. Immunol. 2010, 71:988-991.
34. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
35. Starnes T., et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 2001, 167:4137-4140.
36. Weetman A.P. Graves' disease. N. Engl. J. Med. 2000, 343:1236-1248.
37. Werner S.C. Modification of classification of eye changes of Graves-disease. Am. J. Ophthalmol. 1977, 83:725-727.
38. Xu L., et al. The expression and pathophysiological role of osteopontin in Graves' disease. J. Clin. Endocrinol. Metab. 2011, 96:E1866-1870.
39. Yan N., et al. Association of interleukin-17A and-17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 2012, 45:533-539.
40. Yang X.O., et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 2008, 205:1063-1075.